TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

Klaus H Metzeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.